AR002249A1 - Un compuesto de oxazol, composiciones farmaceuticas que lo contienen, un proceso para la preparacion del mismo y un compuesto intermedio para dichoproceso. - Google Patents
Un compuesto de oxazol, composiciones farmaceuticas que lo contienen, un proceso para la preparacion del mismo y un compuesto intermedio para dichoproceso.Info
- Publication number
- AR002249A1 AR002249A1 ARP950100260A AR10026095A AR002249A1 AR 002249 A1 AR002249 A1 AR 002249A1 AR P950100260 A ARP950100260 A AR P950100260A AR 10026095 A AR10026095 A AR 10026095A AR 002249 A1 AR002249 A1 AR 002249A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- compound
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
En la presente invención se describen compuestos de oxazol que tienen la fórmula (I), en donde R1 y R3 se seleccionan a partir del grupo que consiste dehidrógeno, hidroxi, alquilo de 1 a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono,C1-6alcoxi-C1-6 alquilo,fenilo o fenilo mono-o disustituido conalquilo de 1 a 6 átomos de carbono, halógeno, hidroxi, alcoxi de 1 a 6 átomos de carbono,aminosulfonilo C1-6 alquilsulfonilamino-C1-6 alquilo o carbamil C1-6alquilaminosulfonilo; R2 se selecciona a partir de hidrógeno, alquilo de 1 a 6 átomos de carbono, alcoxi de 1 a 6 átomos de carbono, hidroxi C1-6 alquilo,C1-6alcoxi-C1-6 alquilo o (C1-6 alquilofluorado)oxi-C1-6 alquilo;W es una cadena de alquileno de 1 a 6 átomos de carbono, o nitrógeno; m es independientemente elnúmero entero 0 ó 1; X es CH o nitrógeno, con la condición que cuando W es nitrógeno entonces X es CH; q es independientemente un número enteroselecionado a partir del grupo que consiste de 1, 2, 3 ó 4; ouna sal de adición de base o de adición de ácido farmacéuticamente aceptable del mismo. Lainvención también se refiere a composiciones farmacéuticas que contienen dicho compuesto, a un proceso para la preparación del mismo, y a un compuestointermedio usado en dicho proceso.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9423638A GB9423638D0 (en) | 1994-11-23 | 1994-11-23 | Antagonists of a- 1c adrenergic receptors |
| GBGB9506282.4A GB9506282D0 (en) | 1995-03-28 | 1995-03-28 | Antagonists of A-1C adrenergic receptors |
| GBGB9519885.9A GB9519885D0 (en) | 1995-09-29 | 1995-09-29 | Antagonists of a-1 adrenergic receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002249A1 true AR002249A1 (es) | 1998-03-11 |
Family
ID=27267484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP950100260A AR002249A1 (es) | 1994-11-23 | 1995-11-22 | Un compuesto de oxazol, composiciones farmaceuticas que lo contienen, un proceso para la preparacion del mismo y un compuesto intermedio para dichoproceso. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6090825A (es) |
| EP (1) | EP0793658A1 (es) |
| JP (1) | JPH10509713A (es) |
| AR (1) | AR002249A1 (es) |
| AU (1) | AU4174096A (es) |
| IL (1) | IL116082A0 (es) |
| PE (1) | PE52796A1 (es) |
| WO (1) | WO1996016049A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355641B1 (en) | 1999-03-17 | 2002-03-12 | Syntex (U.S.A.) Llc | Oxazolone derivatives and uses thereof |
| AU3555200A (en) * | 1999-03-17 | 2000-10-04 | F. Hoffmann-La Roche Ag | Oxazolone derivatives and their use as alpha-1 adrenoreceptor modulators |
| US20040216749A1 (en) * | 2003-01-23 | 2004-11-04 | Hosheng Tu | Vasomodulation during glaucoma surgery |
| US7858800B2 (en) * | 2004-06-30 | 2010-12-28 | Banyu Pharmaceutical Co., Ltd. | Biaryl derivatives |
| WO2010080873A1 (en) * | 2009-01-08 | 2010-07-15 | Glaxo Group Limited | Oxazoles as modulators of chemokine receptors |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| JP2017100949A (ja) * | 2014-04-01 | 2017-06-08 | 大日本住友製薬株式会社 | ５員環ヘテロアリール誘導体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1033040B (it) * | 1970-02-21 | 1979-07-10 | Serono Ist Farm | 4 5 difenilossazoli 2 amminometil e 2,2 amminoetil sostituiti |
| US3966748A (en) * | 1975-05-08 | 1976-06-29 | American Cyanamid Company | Para-fluorophenyl-N-heterocyclic substituted butanes |
| GB1527483A (en) * | 1976-02-12 | 1978-10-04 | Mitsubishi Chem Ind | 2-aminomethyl-5-phenyloxazoles and the pharmaceutically acceptable acid addition salts thereof |
| US5324723A (en) * | 1987-09-10 | 1994-06-28 | Merck Sharpe & Dohme Ltd. | Oxazoles and thiazoles for the treatment of senile dementia |
| ES2125285T3 (es) * | 1992-07-31 | 1999-03-01 | Bristol Myers Squibb Co | Derivados inhibidores de la reabsorcion de adenosina de difenil-oxazoles, tiazoles e imidazoles. |
-
1995
- 1995-11-20 WO PCT/EP1995/004552 patent/WO1996016049A1/en not_active Application Discontinuation
- 1995-11-20 EP EP95940209A patent/EP0793658A1/en not_active Ceased
- 1995-11-20 AU AU41740/96A patent/AU4174096A/en not_active Abandoned
- 1995-11-20 US US08/849,016 patent/US6090825A/en not_active Expired - Fee Related
- 1995-11-20 JP JP8516561A patent/JPH10509713A/ja active Pending
- 1995-11-21 IL IL11608295A patent/IL116082A0/xx unknown
- 1995-11-22 AR ARP950100260A patent/AR002249A1/es unknown
- 1995-11-22 PE PE1995285263A patent/PE52796A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10509713A (ja) | 1998-09-22 |
| AU4174096A (en) | 1996-06-17 |
| IL116082A0 (en) | 1996-01-31 |
| EP0793658A1 (en) | 1997-09-10 |
| PE52796A1 (es) | 1996-12-25 |
| WO1996016049A1 (en) | 1996-05-30 |
| US6090825A (en) | 2000-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ307505A (en) | Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds | |
| AR035617A1 (es) | Compuestos derivados de fenetanolamina, combinaciones y formulaciones farmaceuticas de los mismos, proceso para su preparacion, su uso en la preparacion de medicamentos para el tratamiento o profilaxis de una condicion clinica para la cual se indica un agonista beta2 adreno-receptor e intermediarios | |
| AR003930A1 (es) | Procedimiento para preparar compuestos de 2-fenil-3-fenoxi o feniltio-benzotiofeno y sales farmaceuticamente aceptables, compuestos intermediarios de aplicación exclusiva en dicho procedimiento y metodo para preparar los compuestos intermediarios mencionados | |
| CO5271675A1 (es) | Derivados de decahidro-isoquinolinas, proceso para su preparacion, composicion y compuestos farmaceuticos que los contienen | |
| IL154964A0 (en) | Benzsulfonamide derivatives, their preparation and pharmaceutical compositions containing them | |
| AR002249A1 (es) | Un compuesto de oxazol, composiciones farmaceuticas que lo contienen, un proceso para la preparacion del mismo y un compuesto intermedio para dichoproceso. | |
| NO20054053L (no) | Triazolforbindelser anvendbare i terapi. | |
| MXPA03000547A (es) | Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares. | |
| MX174084B (es) | Procedimiento para la preparacion de agentes antiarritmicos producto obtenido y preparacion farmaceutica que lo incluye | |
| IL99652A (en) | Sertindole prodrugs, their preparation and pharmaceutical compositions containing them | |
| EA200500683A1 (ru) | Новые соединения пирролидина и тиазолидина, способ их получения и фармацевтические композиции, которые их содержат | |
| CO5550441A2 (es) | Nuevos derivados de ziprasidona, procedimientos para prepararlos y composiciones que los contienen | |
| EA200100059A3 (ru) | Новые бензолсульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
| AR029618A1 (es) | Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos | |
| CO5080752A1 (es) | INHIBIDORES DEL FACTOR DE TRANSCRIPCION NF-kB | |
| EA200101230A1 (ru) | Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции | |
| CO4920221A1 (es) | Compuestos de naftilo, intermedios, composiciones y procedimientos de uso | |
| KR970705999A (ko) | 타목시펜 및 타목시펜 유사체의 자궁향성 효과를 최소화시키는 방법 (a method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs) | |
| NZ227082A (en) | N-(23-vinblastinoyl) derivatives of 1-aminomethyl-phosphonic acid; process for their preparation; and pharmaceutical compositions containing them | |
| CO4750819A1 (es) | Procedimientos para inhibir el inhibidor del activador del plasminogeno 1 | |
| ES435361A1 (es) | Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos. | |
| EA200300029A1 (ru) | Новые соединения карбамат и тиокарбамат подофиллотоксина, способ их получения и содержащие их фармацевтические композиции | |
| EA200100344A2 (ru) | Новые циклобутаиндолкарбоксамидные производные, способ их получения и содержащие их фармацевтические композиции | |
| RU94044323A (ru) | Средство ингибирования навязчиво-компульсивных состояний и расстройств потребления | |
| FI954213A (fi) | Kasvainten vastaisia koostumuksia ja hoitomenetelmiä |